Exact Mass: 275.1131

Exact Mass Matches: 275.1131

Found 500 metabolites which its exact mass value is equals to given mass value 275.1131, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dimethenamid

2-chloro-N-(2,4-dimethylthiophen-3-yl)-N-(1-methoxypropan-2-yl)acetamide

C12H18ClNO2S (275.0747)


CONFIDENCE standard compound; INTERNAL_ID 586; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9010; ORIGINAL_PRECURSOR_SCAN_NO 9009 CONFIDENCE standard compound; INTERNAL_ID 586; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9035; ORIGINAL_PRECURSOR_SCAN_NO 9034 CONFIDENCE standard compound; INTERNAL_ID 586; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9091; ORIGINAL_PRECURSOR_SCAN_NO 9090 CONFIDENCE standard compound; INTERNAL_ID 586; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9115; ORIGINAL_PRECURSOR_SCAN_NO 9111 CONFIDENCE standard compound; INTERNAL_ID 586; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9100; ORIGINAL_PRECURSOR_SCAN_NO 9097 CONFIDENCE standard compound; INTERNAL_ID 586; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9054; ORIGINAL_PRECURSOR_SCAN_NO 9052 CONFIDENCE standard compound; INTERNAL_ID 3391 CONFIDENCE standard compound; INTERNAL_ID 8390 D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

Gamma-glutamylglutamine

(2S)-2-[(4S)-4-amino-4-carboxybutanamido]-4-carbamoylbutanoic acid

C10H17N3O6 (275.1117)


N2-gamma-Glutamylglutamine, also known as gamma-L-Glu-L-Gln or L-gamma-glutamyl-L-glutamine, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. N2-gamma-Glutamylglutamine is a very strong basic compound (based on its pKa). N2-gamma-Glutamylglutamine is a dipeptide obtained from the condensation of the gamma-carboxy group of glutamic acid with the alpha-amino group of glutamine. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. gamma-Glutamylglutamine has been identified in plasma and cerebrospinal fluid from hyperammonaemic patients. [HMDB] H-γ-Glu-Gln-OH is a hydrophilic peptide and can be conjugated to drugs. The carrier composed of H-γ-Glu-Gln-OH has the characteristics of high water solubility and drug-loading capacity, good biocompatibility, low toxicity, improved tumor targeting ability, and anti-tumor efficacy[1].

   

HOMATROPINE

HOMATROPINE

C16H21NO3 (275.1521)


S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FA - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics Annotation level-1

   

Cardiospermin

(2S)-3-(hydroxymethyl)-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]but-3-enenitrile

C11H17NO7 (275.1005)


   

Sarmentosin

(Z)-2-(hydroxymethyl)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-2-enenitrile

C11H17NO7 (275.1005)


Sarmentosin is found in fruits. Sarmentosin is isolated from Ribes nigrum (blackcurrant

   

Annotine

1,5:4,12b-Dimethano-1H,3H,12bH-oxocino[3,4,5-ij]quinolizin-3-one, 4,5,5a,8,10,11,12,12a-octahydro-5a-hydroxy-4-methyl-, [1R-(1.alpha.,4.beta.,5.alpha.,5a.beta.,12a.alpha.,12b.beta.)]-

C16H21NO3 (275.1521)


   
   

Dubinidine

2-(4-METHOXY-2,3-DIHYDRO-FURO[2,3-B]QUINOLIN-2-YL)-PROPANE-1,2-DIOL

C15H17NO4 (275.1158)


Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids

   

Noratropine

Norhyoscyamine

C16H21NO3 (275.1521)


   

Epinorlycoramine

(-)-N-Demethyllycoramine

C16H21NO3 (275.1521)


   

Dihydro-beta-erythroidine

Dihydro-beta-erythroidine

C16H21NO3 (275.1521)


   

N-Succinyl-L-citrulline

N-Succinyl-L-citrulline

C10H17N3O6 (275.1117)


   

1,6-Anhydro-N-acetyl-beta-muramate

2-(2-Acetylamino-4-hydroxy-6,8-dioxa-bicyclo[3.2.1]oct-3-yloxy)-propionic acid

C11H17NO7 (275.1005)


   

Elwesine

(1R,10R,12S)-4-methoxy-9-azatetracyclo[7.5.2.01,10.02,7]hexadeca-2,4,6-triene-5,12-diol

C16H21NO3 (275.1521)


Elwesine is a natural organic compound belonging to the aporphine alkaloid class. It is found in certain plants and possesses a variety of biological activities, including antibacterial and anti-inflammatory effects. The chemical structure of elwesine features complex cyclic structures, including pyridine and imidazole rings, which contribute to its significance in medicinal and phytochemical research.

   

epsilon-(gamma-Glutamyl)lysine

(2S)-2-amino-6-[(4S)-4-amino-4-carboxybutanamido]hexanoic acid

C11H21N3O5 (275.1481)


In non-diabetic kidney scarring the protein crosslinking enzyme tissue transglutaminase (tTg) has been implicated in the process by the formation of increased epsilon-(gamma-glutamyl)lysine bonds between ECM components in both experimental and human disease. Changes in tTg and epsilon-(gamma-glutamyl)lysine occur in human Diabetic nephropathy as well, the leading cause of chronic kidney failure. (PMID 15292688). In Parkinsons disease (PD), conformational changes in the alpha-synuclein monomer precede the formation of Lewy bodies. Both tTG and its substrate-characteristic N(epsilon)-(gamma-glutamyl)-lysine crosslink are increased in PD nigral dopamine neurons. (PMID 15001552). Expression of tissue transglutaminase (tTgase) and epsilon-(gamma-glutamyl)-lysine was present in all scarring of the blebs sites, being the main cause of failure in glaucoma filtration surgery. Transglutaminases are calcium-dependent enzymes that catalyze the posttranslational modification of proteins through an acyl transfer reaction between the gamma-carboxamide group of a peptide-bound glutaminyl residue and various amines. Covalent cross-linking using epsilon-(gamma-glutamyl)-lysine bonds is stable and resistant to enzymatic, chemical, and mechanical disruption. (PMID: 16936095). In non-diabetic kidney scarring the protein crosslinking enzyme tissue transglutaminase (tTg) has been implicated in the process by the formation of increased epsilon-(gamma-glutamyl)lysine bonds between ECM components in both experimental and human disease. Changes in tTg and epsilon-(gamma-glutamyl)lysine occur in human Diabetic nephropathy as well, the leading cause of chronic kidney failure. (PMID 15292688)

   

Metronidazole Benzoate

Metronidazole Benzoate

C13H13N3O4 (275.0906)


A benzoate ester resulting from the formal condensation of benzoic acid with the hydroxy group of metronidazole. C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent C784 - Protein Synthesis Inhibitor

   
   

2-Acetamido-4-(D-alanylamino)-2,4,6-trideoxy-D-mannopyranose

2-Acetamido-4-(D-alanylamino)-2,4,6-trideoxy-D-mannopyranose

C11H21N3O5 (275.1481)


   

4'-hydroxypropanolol

4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}naphthalen-1-ol

C16H21NO3 (275.1521)


4-hydroxypropanolol is a metabolite of propranolol. Propranolol is a sympatholytic non-selective beta blocker. Sympatholytics are used to treat hypertension, anxiety and panic. It was the first successful beta blocker developed. Propranolol is available in generic form as propranolol hydrochloride, as well as an AstraZeneca and Wyeth product under the brand names Inderal, Inderal LA, Avlocardyl, Deralin, Dociton, Inderalici, InnoPran XL, Sumial, Anaprilinum, Bedranol SR. (Wikipedia)

   

Glutamylglutamine

(2S)-2-{[(2S)-2-amino-4-carboxy-1-hydroxybutylidene]amino}-4-(C-hydroxycarbonimidoyl)butanoate

C10H17N3O6 (275.1117)


Glutamylglutamine is a dipeptide composed of glutamate and glutamine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamylglutamine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

(±)-Ribaline

6-hydroxy-2-(2-hydroxypropan-2-yl)-9-methyl-2H,3H,4H,9H-furo[2,3-b]quinolin-4-one

C15H17NO4 (275.1158)


Minor alkaloid from Ruta graveolens (rue). (±)-Ribaline is found in herbs and spices. (±)-Ribaline is found in herbs and spices. Minor alkaloid from Ruta graveolens (rue).

   

gamma-Glutamyllysine

(2S)-6-Amino-2-{[(4S)-4-amino-4-carboxy-1-hydroxybutylidene]amino}hexanoate

C11H21N3O5 (275.1481)


gamma-Glutamyllysine is a dipeptide composed of gamma-glutamate and lysine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. gamma-Glutamyllysine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

4,5-Dihydropiperlonguminine

(2E)-5-(2H-1,3-Benzodioxol-5-yl)-N-(2-methylpropyl)pent-2-enimidate

C16H21NO3 (275.1521)


4,5-Dihydropiperlonguminine is found in herbs and spices. 4,5-Dihydropiperlonguminine is an alkaloid from fruits of Piper longum (long pepper). Alkaloid from fruits of Piper longum (long pepper). 4,5-Dihydropiperlonguminine is found in herbs and spices.

   

Norophthalmic acid

(2S)-2-Amino-4-{[(1S)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]-C-hydroxycarbonimidoyl}butanoate

C10H17N3O6 (275.1117)


Norophthalmic acid (y-glutamyl-alanyl-glycine) is an analogue of glutathione (L-cysteine replaced by L-alanine) isolated from crystalline lens. [HMDB] Norophthalmic acid (y-glutamyl-alanyl-glycine) is an analogue of glutathione (L-cysteine replaced by L-alanine) isolated from crystalline lens.

   

Ethenodeoxyadenosine

(2R,3S,5R)-2-(hydroxymethyl)-5-{3H-imidazo[2,1-f]purin-3-yl}oxolan-3-ol

C12H13N5O3 (275.1018)


Etheno nucleosides are a new class of chemically modified components of nucleic acids. These base-modified nucleosides demonstrate significant biological properties, acting, among others, as antiviral or antitumor agents. One of the possible modifications of the nucleoside is their transformation into ethenonucleosides. Thus, nucleosides or their respective heterocyclic bases, possessing an exocyclic amino group, as well as a neighboring endocyclic nitrogen, can react with some bifunctional reagents (e.g., α-halocarbonyl compounds) to form products with an additional five-membered ring of the imidazole type. The ethenonucleosides basically do not occur in nature; some of the only exceptions are Y-nucleosides. Etheno modified DNA bases are generated from the carcinogens vinyl chloride and urethane, but also by reactions of DNA with products derived from lipid peroxidation (LPO) and oxidative stress via endogenous pathways. Highly variable background levels of epsilon-adducts were detected in DNA from different organs of unexposed humans and rodents. Several known cancer risk factors increased the level of these DNA lesions in target organs: elevated epsilon-adducts were found in hepatic DNA from patients with metal storage diseases, after overproduction of nitric oxide (NO) by inducible NO synthase (iNOS) in a mouse model, and in colonic polyps of familial adenomatous polyposis patients. A high omega-6-polyunsaturated fatty acid diet increased epsilon-DNA adducts in white blood cells of female subjects. (PMID:10882861). Etheno (epsilon) modified DNA bases are generated from the carcinogens vinyl chloride and urethane, but also by reactions of DNA with products derived from lipid peroxidation (LPO) and oxidative stress via endogenous pathways. Highly variable background levels of epsilon-adducts were detected in DNA from different organs of unexposed humans and rodents. Several known cancer risk factors increased the level of these DNA lesions in target organs: elevated epsilon-adducts were found in hepatic DNA from patients with metal storage diseases, after overproduction of nitric oxide (NO) by inducible NO synthase (iNOS) in a mouse model, and in colonic polyps of familial adenomatous polyposis patients. A high omega-6-polyunsaturated fatty acid diet increased epsilon-DNA adducts in white blood cells of female subjects. (PMID: 10882861) [HMDB] N6-Etheno 2'-deoxyadenosine is a reactive oxygen species (ROS)/reactive nitrogen species (RNS)-induced DNA oxidation product, used as a biomarker to evaluate chronic inflammation and lipid peroxidation in animal or human tissues[1].

   

Lysylglutamic acid

(2S)-2-[(2S)-2,6-diaminohexanamido]pentanedioic acid

C11H21N3O5 (275.1481)


Lysylglutamic acid is a dipeptide composed of lysine and glutamic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutaminylglutamic acid

(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]pentanedioic acid

C10H17N3O6 (275.1117)


Glutaminylglutamic acid is a dipeptide composed of glutamine and glutamic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutamyllysine

(2S)-6-amino-2-[(2S)-2-amino-4-carboxybutanamido]hexanoic acid

C11H21N3O5 (275.1481)


Glutamyllysine is a dipeptide composed of glutamate and lysine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamyllysine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. The absorption of glutamyllysine is facilitated by the human intestinal oligopeptide transporter (PEPT1) (PMID 16759105). Glutamyl-L-lysine is a dipeptide whose absorption is facilitated by the human intestinal oligopeptide transporter (PEPT1) (PMID 16759105).

   

Tryptophyl-Alanine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}propanoate

C14H17N3O3 (275.127)


Tryptophyl-Alanine is a dipeptide composed of tryptophan and alanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Glutarylcarnitine (C5-DC)

(3R)-3-[(4-carboxybutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H21NO6 (275.1369)


Glutarylcarnitine is an acylcarnitine. More specifically, it is an glutaric acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Glutarylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine glutarylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). Glutarylcarnitine has been identified in the human placenta (PMID: 32033212 ). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. Glutarylcarnitine is the diagnostic metabolite for malonic aciduria and glutaric aciduria type I monitored in most tandem mass spectrometry newborn screening programmes.

   

Alanyltryptophan

(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanoic acid

C14H17N3O3 (275.127)


Alanyltryptophan is a dipeptide composed of alanine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutamyl-Gamma-glutamate

2-Amino-4-[(2-amino-4-carboxybutanoyl)-C-hydroxycarbonimidoyl]butanoate

C10H17N3O6 (275.1117)


Glutamyl-Gamma-glutamate is a dipeptide composed of glutamate and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

N-gamma-Glutamylglutamine

(2S)-2-Amino-4-{[(4S)-4-amino-4-carboxybutanoyl]-C-hydroxycarbonimidoyl}butanoate

C10H17N3O6 (275.1117)


N-gamma-Glutamylglutamine is a dipeptide obtained from condensation of the gamma-carboxy group of glutamic acid with the side-chain amide group of glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

5-Amino-6-(4-hydroxy-2-butenoyl)-2,2-dimethyl-4-chromanone

5-amino-6-[(2E)-4-hydroxybut-2-enoyl]-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-one

C15H17NO4 (275.1158)


5-Amino-6-(4-hydroxy-2-butenoyl)-2,2-dimethyl-4-chromanone is produced by Fusarium equiseti. Production by Fusarium equiseti

   

O-Glutarylcarnitine

3-[(4-Carboxybutanoyl)oxy]-4-(trimethylammonio)butanoic acid

C12H21NO6 (275.1369)


O-Glutarylcarnitine is an acylcarnitine. More specifically, it is an glutaric acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. O-Glutarylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine O-Glutarylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Ethylpropanedioylcarnitine

3-[(2-carboxy-2-ethylacetyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H21NO6 (275.1369)


2-Ethylpropanedioylcarnitine is an acylcarnitine. More specifically, it is an 2-ethylpropanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Ethylpropanedioylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 2-Ethylpropanedioylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N6-Etheno 2'-deoxyadenosine

2-(hydroxymethyl)-5-{3H-imidazo[2,1-f]purin-3-yl}oxolan-3-ol

C12H13N5O3 (275.1018)


N6-Etheno 2'-deoxyadenosine is a reactive oxygen species (ROS)/reactive nitrogen species (RNS)-induced DNA oxidation product, used as a biomarker to evaluate chronic inflammation and lipid peroxidation in animal or human tissues[1].

   

Benzoylnorecgonine

3-(benzoyloxy)-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C15H17NO4 (275.1158)


   

Dihydro-beta-erythroidine

16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),13-dien-4-one

C16H21NO3 (275.1521)


   

I - homatrine

8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2-phenylacetic acid

C16H21NO3 (275.1521)


   

Ibafloxacin

7-fluoro-8,12-dimethyl-4-oxo-1-azatricyclo[7.3.1.0⁵,¹³]trideca-2,5(13),6,8-tetraene-3-carboxylic acid

C15H14FNO3 (275.0958)


   

lavendustin c

5-{[(2,5-dihydroxyphenyl)methyl]amino}-2-hydroxybenzoic acid

C14H13NO5 (275.0794)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor

   

Methylenedioxypyrovalerone

1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one

C16H21NO3 (275.1521)


   

Metronidazole benzoate

2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl benzoate

C13H13N3O4 (275.0906)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent C784 - Protein Synthesis Inhibitor

   

1-((2-Methyl-5-methylene-5-oxotetrahydrofuran-2-yl)methyl)guanine

2-amino-1-[(2-methyl-4-methylidene-5-oxooxolan-2-yl)methyl]-6,7-dihydro-1H-purin-6-one

C12H13N5O3 (275.1018)


   

Rolipram

3-[3-(cyclopentyloxy)-4-methoxyphenyl]-3,4-dihydro-2H-pyrrol-5-ol

C16H21NO3 (275.1521)


D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058988 - Phosphodiesterase 4 Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   

1-(3-Hydroxy-2,2,6-trimethyl-3,4-dihydrochromen-4-yl)pyrrolidin-2-one

1-(3-hydroxy-2,2,6-trimethyl-3,4-dihydro-2H-1-benzopyran-4-yl)pyrrolidin-2-one

C16H21NO3 (275.1521)


   

epsilon-(gamma-Glutamyl)-L-lysine

2,6,10-triamino-5-oxoundecanedioic acid

C11H21N3O5 (275.1481)


   

(2S,3S,5R)-5-(6-Aminopurin-9-yl)-2-(2H-oxet-2-yl)oxolan-3-ol

(2S,3S,5R)-5-(6-Aminopurin-9-yl)-2-(2H-oxet-2-yl)oxolan-3-ol

C12H13N5O3 (275.1018)


   

[(1S,2S,4S,5S)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)-4-bicyclo[3.1.0]hexanyl]methanol

[(1S,2S,4S,5S)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)-4-bicyclo[3.1.0]hexanyl]methanol

C13H17N5O2 (275.1382)


   

1-(3,4-Dimethoxycinnamoyl)piperidine

2-Propen-1-one, 3-(3,4-dimethoxyphenyl)-1-(1-piperidinyl)-, (2E)-

C16H21NO3 (275.1521)


   

O-Demethyllycoramine

O-Demethyllycoramine

C16H21NO3 (275.1521)


   
   
   

Isoelaeocarpicine

Isoelaeocarpicine

C16H21NO3 (275.1521)


   

5-Deoxytoyocamycin

5-Deoxytoyocamycin

C12H13N5O3 (275.1018)


   
   

Norlycoramine

Norlycoramine

C16H21NO3 (275.1521)


   

Imazapic

Imazapic

C14H17N3O3 (275.127)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3452; ORIGINAL_PRECURSOR_SCAN_NO 3451 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3472; ORIGINAL_PRECURSOR_SCAN_NO 3470 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3387; ORIGINAL_PRECURSOR_SCAN_NO 3385 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3462; ORIGINAL_PRECURSOR_SCAN_NO 3461 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3400; ORIGINAL_PRECURSOR_SCAN_NO 3398 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3396; ORIGINAL_PRECURSOR_SCAN_NO 3394 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7071; ORIGINAL_PRECURSOR_SCAN_NO 7067 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7108; ORIGINAL_PRECURSOR_SCAN_NO 7106 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7114; ORIGINAL_PRECURSOR_SCAN_NO 7111 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7134; ORIGINAL_PRECURSOR_SCAN_NO 7132 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7141; ORIGINAL_PRECURSOR_SCAN_NO 7139 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7149; ORIGINAL_PRECURSOR_SCAN_NO 7147

   

Methylenedioxypyrovalerone

1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone

C16H21NO3 (275.1521)


D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants

   

2,3-Methylenedioxypyrovalerone

2,3-Methylenedioxypyrovalerone

C16H21NO3 (275.1521)


   

rolipram

Rolipram aka 4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one

C16H21NO3 (275.1521)


D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058988 - Phosphodiesterase 4 Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   
   

N1-(2,4-Dimethoxyphenyl)-2-cyano-3-(dimethylamino)acrylamide

N1-(2,4-Dimethoxyphenyl)-2-cyano-3-(dimethylamino)acrylamide

C14H17N3O3 (275.127)


   

Maybridge3_002657

Maybridge3_002657

C14H17N3OS (275.1092)


   

Oprea1_237049

Oprea1_237049

C15H21N3S (275.1456)


   

NCIOpen2_008939

NCIOpen2_008939

C15H17NO4 (275.1158)


   
   
   
   

2-(1,2-dihydroxy-1-methyl-ethyl)-9-methyl-3,9-dihydro-2H-furo[2,3-b]quinolin-4-one|Folisin|Folisine

2-(1,2-dihydroxy-1-methyl-ethyl)-9-methyl-3,9-dihydro-2H-furo[2,3-b]quinolin-4-one|Folisin|Folisine

C15H17NO4 (275.1158)


   
   

Obscurolide-D2

Obscurolide-D2

C15H17NO4 (275.1158)


   

(Z)-1-(4,5-Methylenedioxy-2-methoxycinnamoyl)pyrrolidine|N-[3-(3,4-methylenedioxy,6-methoxyphenyl)-2(Z)-propenoyl]pyrrolidine|N-[3-(6-Methoxy-3,4-methylenedioxyphenyl)-2(Z)-propenoyl]pyrrolidine

(Z)-1-(4,5-Methylenedioxy-2-methoxycinnamoyl)pyrrolidine|N-[3-(3,4-methylenedioxy,6-methoxyphenyl)-2(Z)-propenoyl]pyrrolidine|N-[3-(6-Methoxy-3,4-methylenedioxyphenyl)-2(Z)-propenoyl]pyrrolidine

C15H17NO4 (275.1158)


   
   

jatropham 5-O-beta-D-glucopyranoside

jatropham 5-O-beta-D-glucopyranoside

C11H17NO7 (275.1005)


   
   

5-methoxy-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]quinoline-3,7-diol|N-demethyl-O-methyl-ribalinidine|Ribalinidin

5-methoxy-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]quinoline-3,7-diol|N-demethyl-O-methyl-ribalinidine|Ribalinidin

C15H17NO4 (275.1158)


   
   

triethyl 1-aminopropane-1,2,3-tricarboxylate

triethyl 1-aminopropane-1,2,3-tricarboxylate

C12H21NO6 (275.1369)


   

(2E,4E,6E)-N-isopentyl-7-(2-thienyl)-2,4,6-heptatrienamide

(2E,4E,6E)-N-isopentyl-7-(2-thienyl)-2,4,6-heptatrienamide

C16H21NOS (275.1344)


   
   

d-Ribalinidine

d-Ribalinidine

C15H17NO4 (275.1158)


   

osmaronin epoxide|osmaroninepoxide

osmaronin epoxide|osmaroninepoxide

C11H17NO7 (275.1005)


   

(-)-debromoeudistomin K|(-)-Debromoeudistomin L|Debromoeudistomin K|debromoeudistomin K trifluoroacetate

(-)-debromoeudistomin K|(-)-Debromoeudistomin L|Debromoeudistomin K|debromoeudistomin K trifluoroacetate

C14H17N3OS (275.1092)


   

alpha-deS-Glutathione|H-alpha-Glu-Ala-Gly-OH|norophthalmic acid

alpha-deS-Glutathione|H-alpha-Glu-Ala-Gly-OH|norophthalmic acid

C10H17N3O6 (275.1117)


   

2-(1-hydroxy-1-methyl-ethyl)-4-methoxy-2,3-dihydro-furo[2,3-b]quinolin-3-ol|Myrtopsin|Myrtopsine|trans-2,3-dihydro-3-hydroxy-4-methoxy-alpha,alpha-dimethylfuro[2,3-b]quinoline-2-methanol

2-(1-hydroxy-1-methyl-ethyl)-4-methoxy-2,3-dihydro-furo[2,3-b]quinolin-3-ol|Myrtopsin|Myrtopsine|trans-2,3-dihydro-3-hydroxy-4-methoxy-alpha,alpha-dimethylfuro[2,3-b]quinoline-2-methanol

C15H17NO4 (275.1158)


   

alanyltryptophan

alanyltryptophan

C14H17N3O3 (275.127)


Alanyltryptophan is a derivative of tryptophan. Tryptophan is an essential amino acid which is the precursor of serotonin. [HMDB]

   

Obscurolide B2alpha|Obscurolide B2beta

Obscurolide B2alpha|Obscurolide B2beta

C15H17NO4 (275.1158)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

lavendustin c

lavendustin c

C14H13NO5 (275.0794)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor

   
   
   
   
   

Guanine derivative

Guanine derivative

C12H13N5O3 (275.1018)


   

Dimethenamid

dimethenamid-P

C12H18ClNO2S (275.0747)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 254

   

gamma-Glutamylglutamine

gamma-Glutamylglutamine

C10H17N3O6 (275.1117)


H-γ-Glu-Gln-OH is a hydrophilic peptide and can be conjugated to drugs. The carrier composed of H-γ-Glu-Gln-OH has the characteristics of high water solubility and drug-loading capacity, good biocompatibility, low toxicity, improved tumor targeting ability, and anti-tumor efficacy[1].

   

bupropion hydrochloride

Amfebutamone (Bupropion)

C13H19Cl2NO (275.0844)


D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065690 - Cytochrome P-450 CYP2D6 Inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators D000077444 - Smoking Cessation Agents

   

DUBINIDINE

NCGC00015366-03!DUBINIDINE

C15H17NO4 (275.1158)


   

4-[[2-[(E)-3-hydroxybut-1-enyl]-5-oxooxolan-3-yl]amino]benzaldehyde

NCGC00244969-01!4-[[2-[(E)-3-hydroxybut-1-enyl]-5-oxooxolan-3-yl]amino]benzaldehyde

C15H17NO4 (275.1158)


   

(4E,6E)-3-(4-formylanilino)-8-hydroxyocta-4,6-dienoic acid

NCGC00380354-01!(4E,6E)-3-(4-formylanilino)-8-hydroxyocta-4,6-dienoic acid

C15H17NO4 (275.1158)


   

C15H17NO4

NCGC00380986-01_C15H17NO4_

C15H17NO4 (275.1158)


   

C13H13N3O4

NCGC00385407-01_C13H13N3O4_

C13H13N3O4 (275.0906)


   

Ethenodeoxyadenosine

(2R,3S)-2-(hydroxymethyl)-5-imidazo[2,1-f]purin-3-yloxolan-3-ol

C12H13N5O3 (275.1018)


N6-Etheno 2'-deoxyadenosine is a reactive oxygen species (ROS)/reactive nitrogen species (RNS)-induced DNA oxidation product, used as a biomarker to evaluate chronic inflammation and lipid peroxidation in animal or human tissues[1].

   
   

H-gamma-glutamyl-glutamine

H-gamma-glutamyl-glutamine

C10H17N3O6 (275.1117)


   
   

7-ethenyl-1,4a,7-trimethyl-3,4,6,8,8a,9,10,10a-octahydro-2H-phenanthrene-1-carboxylic acid

7-ethenyl-1,4a,7-trimethyl-3,4,6,8,8a,9,10,10a-octahydro-2H-phenanthrene-1-carboxylic acid

C15H17NO4 (275.1158)


   

Glutaryl-carnitine; AIF; CE00; CorrDec

Glutaryl-carnitine; AIF; CE00; CorrDec

C12H21NO6 (275.1369)


   

Glutaryl-carnitine; AIF; CE10; CorrDec

Glutaryl-carnitine; AIF; CE10; CorrDec

C12H21NO6 (275.1369)


   

Glutaryl-carnitine; AIF; CE30; CorrDec

Glutaryl-carnitine; AIF; CE30; CorrDec

C12H21NO6 (275.1369)


   

Glutaryl-carnitine; AIF; CE0; MS2Dec

Glutaryl-carnitine; AIF; CE0; MS2Dec

C12H21NO6 (275.1369)


   

Glutaryl-carnitine; AIF; CE10; MS2Dec

Glutaryl-carnitine; AIF; CE10; MS2Dec

C12H21NO6 (275.1369)


   

Glutaryl-carnitine; AIF; CE30; MS2Dec

Glutaryl-carnitine; AIF; CE30; MS2Dec

C12H21NO6 (275.1369)


   

Glutarylcarnitine

Glutarylcarnitine

C12H21NO6 (275.1369)


Glutarylcarnitine is the diagnostic metabolite for malonic aciduria and glutaric aciduria type I monitored in most tandem mass spectrometry newborn screening programmes.

   

O4-Pyridylhydroxybutyl-thymine

O4-Pyridylhydroxybutyl-thymine

C14H17N3O3 (275.127)


   

3-Pyridylhydroxybutyl-thymine

3-Pyridylhydroxybutyl-thymine

C14H17N3O3 (275.127)


   

O2-Pyridylhydroxybutyl-thymine

O2-Pyridylhydroxybutyl-thymine

C14H17N3O3 (275.127)


   

1,N6-Etheno-deoxyadenosine

1,N6-Etheno-deoxyadenosine

C12H13N5O3 (275.1018)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Ε-(γ-glu)-LYS

Ε-(γ-glutamyl)lysine isodipeptide

C11H21N3O5 (275.1481)


   

Glutamyllysine

N2-L-alpha-Glutamyl-lysine

C11H21N3O5 (275.1481)


   

Norophthalmic acid

gamma-Glutamyl-alanyl-glycine

C10H17N3O6 (275.1117)


A tripeptide composed of L-glutamic acid, L-alanine, and glycine residues joined in sequence by peptide linkages.

   

Ala-Trp

2-[2-amino-3-(1H-indol-3-yl)propanamido]propanoic acid

C14H17N3O3 (275.127)


A dipeptide formed from L-alanyl and L-tryptophan residues.

   

TRP-Ala

2-(2-aminopropanamido)-3-(1H-indol-3-yl)propanoic acid

C14H17N3O3 (275.127)


A dipeptide formed from L-tryptophan and L-alanine residues.

   

Ribaline

6-hydroxy-2-(2-hydroxypropan-2-yl)-9-methyl-2H,3H,4H,9H-furo[2,3-b]quinolin-4-one

C15H17NO4 (275.1158)


   

5-Amino-6-(4-hydroxy-2-butenoyl)-2,2-dimethyl-4-chromanone

5-amino-6-[(2E)-4-hydroxybut-2-enoyl]-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-one

C15H17NO4 (275.1158)


   

CAR 5:1;O2

3-[(4-carboxybutanoyl)oxy]-4-(trimethylammonio)butanoate;glutarylcarnitine

C12H21NO6 (275.1369)


   

Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(phenylmethyl)- (9CI)

Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(phenylmethyl)- (9CI)

C18H17N3 (275.1422)


   

cis-2-(benzyloxycarbonylamino)-4-cyclohexene-1-carboxylic acid

cis-2-(benzyloxycarbonylamino)-4-cyclohexene-1-carboxylic acid

C15H17NO4 (275.1158)


   

1-Cbz-Piperidin-4-ylidene-acetic acid

1-Cbz-Piperidin-4-ylidene-acetic acid

C15H17NO4 (275.1158)


   

(3,5-DIMETHYL-4-ISOXAZOLYL)METHANOL

(3,5-DIMETHYL-4-ISOXAZOLYL)METHANOL

C14H13NO5 (275.0794)


   

Butanamide,N-(1,3-dioxobutyl)-N-(2-methylphenyl)-3-oxo-

Butanamide,N-(1,3-dioxobutyl)-N-(2-methylphenyl)-3-oxo-

C15H17NO4 (275.1158)


   

5,6-DIHYDRO-BENZO[C]ACRIDINE-7-CARBOXYLIC ACID

5,6-DIHYDRO-BENZO[C]ACRIDINE-7-CARBOXYLIC ACID

C18H13NO2 (275.0946)


   

[7-methyl-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

[7-methyl-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

C14H18BNO4 (275.1329)


   

[4-(Diphenylamino)phenyl]methanol

[4-(Diphenylamino)phenyl]methanol

C19H17NO (275.131)


   

3-(1-Oxo-4-Phenylphthalazin-2(1H)-yl)propaneitrile

3-(1-Oxo-4-Phenylphthalazin-2(1H)-yl)propaneitrile

C17H13N3O (275.1059)


   

propan-2-yl 2-amino-4-(4-methylphenyl)thiophene-3-carboxylate

propan-2-yl 2-amino-4-(4-methylphenyl)thiophene-3-carboxylate

C15H17NO2S (275.098)


   

Phenyl (4,6-dimethoxy-2-pyrimidinyl)carbamate

Phenyl (4,6-dimethoxy-2-pyrimidinyl)carbamate

C13H13N3O4 (275.0906)


   

1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidine-4-carboxylic acid

1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidine-4-carboxylic acid

C11H12F3N3O2 (275.0882)


   

1-(TERT-BUTYL) 2-METHYL 1H-INDOLE-1,2-DICARBOXYLATE

1-(TERT-BUTYL) 2-METHYL 1H-INDOLE-1,2-DICARBOXYLATE

C15H17NO4 (275.1158)


   

2-AMINO-4-(4-ISOPROPYL-PHENYL)-THIOPHENE-3-CARBOXYLIC ACID METHYL ESTER

2-AMINO-4-(4-ISOPROPYL-PHENYL)-THIOPHENE-3-CARBOXYLIC ACID METHYL ESTER

C15H17NO2S (275.098)


   

N-(4-CHLOROPHENYL)-N-(4,6-DIMETHYLPYRIMIDIN-2-YL)GUANIDINE

N-(4-CHLOROPHENYL)-N-(4,6-DIMETHYLPYRIMIDIN-2-YL)GUANIDINE

C13H14ClN5 (275.0938)


   

N,N-dibutyl-4,6-dichloro-pyrimidin-2-amine

N,N-dibutyl-4,6-dichloro-pyrimidin-2-amine

C12H19Cl2N3 (275.0956)


   

Tetraethylammonium hexafluorophosphate

Tetraethylammonium hexafluorophosphate

C8H20F6NP (275.1237)


   

ETHYL 2-(4-ISOPROPYLPHENYL)THIAZOLE-5-CARBOXYLATE

ETHYL 2-(4-ISOPROPYLPHENYL)THIAZOLE-5-CARBOXYLATE

C15H17NO2S (275.098)


   

4-(5-amino-4-ethoxycarbonylpyrazol-1-yl)benzoic acid

4-(5-amino-4-ethoxycarbonylpyrazol-1-yl)benzoic acid

C13H13N3O4 (275.0906)


   

METHYL 3-(2-CARBOXY-VINYL)-6-METHOXY-1H-INDOLE-2-CARBOXYLATE

METHYL 3-(2-CARBOXY-VINYL)-6-METHOXY-1H-INDOLE-2-CARBOXYLATE

C14H13NO5 (275.0794)


   

2-AMINO-4-(4-ETHYLPHENYL)-5-METHYLTHIOPHENE-3-CARBOXYLICACIDMETHYLESTER

2-AMINO-4-(4-ETHYLPHENYL)-5-METHYLTHIOPHENE-3-CARBOXYLICACIDMETHYLESTER

C15H17NO2S (275.098)


   

tipepidine

tipepidine

C15H17NS2 (275.0802)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent

   

1-[4-nitro-2-(trifluoromethyl)phenyl]piperazine

1-[4-nitro-2-(trifluoromethyl)phenyl]piperazine

C11H12F3N3O2 (275.0882)


   
   

METHYL 2-OXO-1-(PIPERIDIN-4-YL)-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE

METHYL 2-OXO-1-(PIPERIDIN-4-YL)-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE

C14H17N3O3 (275.127)


   

benzphetamine hydrochloride

benzyl-methyl-[(2S)-1-phenylpropan-2-yl]azanium;chloride

C17H22ClN (275.1441)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents C78272 - Agent Affecting Nervous System > C29728 - Anorexiant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

METHYL 2-((1,3-DIOXOISOINDOLIN-2-YL)METHYL)-3-OXOBUTANOATE

METHYL 2-((1,3-DIOXOISOINDOLIN-2-YL)METHYL)-3-OXOBUTANOATE

C14H13NO5 (275.0794)


   

5-[(4-methoxyphenyl)methoxy]-4-oxo-1H-pyridine-2-carboxylic acid

5-[(4-methoxyphenyl)methoxy]-4-oxo-1H-pyridine-2-carboxylic acid

C14H13NO5 (275.0794)


   

ETHYL 2-(4-ISOPROPYLPHENYL)THIAZOLE-4-CARBOXYLATE

ETHYL 2-(4-ISOPROPYLPHENYL)THIAZOLE-4-CARBOXYLATE

C15H17NO2S (275.098)


   

3-nitro-trans-beta-styrylboronic acid pinacol ester

3-nitro-trans-beta-styrylboronic acid pinacol ester

C14H18BNO4 (275.1329)


   

1-TERT-BUTYL 5-METHYL 1H-INDOLE-1,5-DICARBOXYLATE

1-TERT-BUTYL 5-METHYL 1H-INDOLE-1,5-DICARBOXYLATE

C15H17NO4 (275.1158)


   

Ethanol,2,2,2-nitrilotris-, 1,1,1-triacetate

Ethanol,2,2,2-nitrilotris-, 1,1,1-triacetate

C12H21NO6 (275.1369)


   

methyl 3-(2-carboxy-vinyl)-4-methoxy-1h-indole-2-carboxylate

methyl 3-(2-carboxy-vinyl)-4-methoxy-1h-indole-2-carboxylate

C14H13NO5 (275.0794)


   

N-BOC-THIOMORPHOLINE-3-CARBOXYLIC ACID ETHYL ESTER

N-BOC-THIOMORPHOLINE-3-CARBOXYLIC ACID ETHYL ESTER

C12H21NO4S (275.1191)


   

2-[1-[(2-methylpropan-2-yl)oxycarbonyl]indol-3-yl]acetic acid

2-[1-[(2-methylpropan-2-yl)oxycarbonyl]indol-3-yl]acetic acid

C15H17NO4 (275.1158)


   

Boc-Glu(Ome)-OMe

Boc-Glu(Ome)-OMe

C12H21NO6 (275.1369)


   

2 6-DIPHENYLISONICOTINIC ACID

2 6-DIPHENYLISONICOTINIC ACID

C18H13NO2 (275.0946)


   

4-[(4-METHYLPHENYL)SULFONYL]PIPERIDINEHYDROCHLORIDE

4-[(4-METHYLPHENYL)SULFONYL]PIPERIDINEHYDROCHLORIDE

C12H18ClNO2S (275.0747)


   

Dimethylmethyldopa

Dimethylmethyldopa

C12H18ClNO4 (275.0924)


   

4-(4-METHOXY-2,5-DIMETHYL-PHENYL)-5-METHYL-THIAZOL-2-YLAMINE

4-(4-METHOXY-2,5-DIMETHYL-PHENYL)-5-METHYL-THIAZOL-2-YLAMINE

C14H17N3O3 (275.127)


   

ETHYL 2-METHYL-5-(3-NITROPHENYL)-3-FUROATE

ETHYL 2-METHYL-5-(3-NITROPHENYL)-3-FUROATE

C14H13NO5 (275.0794)


   

GW441756

1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one

C17H13N3O (275.1059)


   

2-Morpholino-5-(trifluoromethyl)benzoic acid

2-Morpholino-5-(trifluoromethyl)benzoic acid

C12H12F3NO3 (275.0769)


   

3-Amino-3-(3,4-dimethoxy-phenyl)-propionic acid methyl ester hydrochloride

3-Amino-3-(3,4-dimethoxy-phenyl)-propionic acid methyl ester hydrochloride

C12H18ClNO4 (275.0924)


   

3-Deschloro-2-Chloro Bupropion HCl

3-Deschloro-2-Chloro Bupropion HCl

C13H19Cl2NO (275.0844)


   

Methyl 5,5,5-trifluoro-4-(M-tolylamino)pentanoate

Methyl 5,5,5-trifluoro-4-(M-tolylamino)pentanoate

C13H16F3NO2 (275.1133)


   

Methyl 5,5,5-trifluoro-4-(o-tolylamino)pentanoate

Methyl 5,5,5-trifluoro-4-(o-tolylamino)pentanoate

C13H16F3NO2 (275.1133)


   

5,5,5-TRIFLUORO-4-P-TOLYLAMINO-PENTANOIC ACID METHYL ESTER

5,5,5-TRIFLUORO-4-P-TOLYLAMINO-PENTANOIC ACID METHYL ESTER

C13H16F3NO2 (275.1133)


   

3-hydroxy-N-(1-methylpyrazol-3-yl)-5-propan-2-yloxybenzamide

3-hydroxy-N-(1-methylpyrazol-3-yl)-5-propan-2-yloxybenzamide

C14H17N3O3 (275.127)


   

GR 135531

5-Methoxycarbonylamino-N-acetyltryptamine

C14H17N3O3 (275.127)


   

(2,4-DIMETHOXY-BENZYL)-(4-FLUORO-BENZYL)-AMINE

(2,4-DIMETHOXY-BENZYL)-(4-FLUORO-BENZYL)-AMINE

C16H18FNO2 (275.1322)


   

2-AMINO-4-(2,4-DIMETHYLPHENYL)-5-METHYLTHIOPHENE-3-CARBOXYLICACIDMETHYLESTER

2-AMINO-4-(2,4-DIMETHYLPHENYL)-5-METHYLTHIOPHENE-3-CARBOXYLICACIDMETHYLESTER

C15H17NO2S (275.098)


   

N-(TERT-BUTYL)-5-ISOBUTYLTHIOPHENE-2-SULFONAMIDE

N-(TERT-BUTYL)-5-ISOBUTYLTHIOPHENE-2-SULFONAMIDE

C12H21NO2S2 (275.1014)


   

Cbz-2-amino-2-furanacetic acid

Cbz-2-amino-2-furanacetic acid

C14H13NO5 (275.0794)


   

7-Diethylamino-2-Oxo-Chromene-3-Carbohydrazide

7-Diethylamino-2-Oxo-Chromene-3-Carbohydrazide

C14H17N3O3 (275.127)


   

4,4,5,5-tetramethyl-2-[(E)-2-(4-nitrophenyl)ethenyl]-1,3,2-dioxaborolane

4,4,5,5-tetramethyl-2-[(E)-2-(4-nitrophenyl)ethenyl]-1,3,2-dioxaborolane

C14H18BNO4 (275.1329)


   

N-[2-nitro-4-(trifluoromethyl)phenyl]piperazine

N-[2-nitro-4-(trifluoromethyl)phenyl]piperazine

C11H12F3N3O2 (275.0882)


   

tris(2-hydroxyethyl)methylammonium methyl sulphate

tris(2-hydroxyethyl)methylammonium methyl sulphate

C8H21NO7S (275.1039)


   

2,4-dioxo-4-(4-piperidin-1-ylphenyl)butanoic acid

2,4-dioxo-4-(4-piperidin-1-ylphenyl)butanoic acid

C15H17NO4 (275.1158)


   

Ethyl 2-amino-4-(3,4-dimethylphenyl)thiophene-3-carboxylate

Ethyl 2-amino-4-(3,4-dimethylphenyl)thiophene-3-carboxylate

C15H17NO2S (275.098)


   

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one

C14H18BNO4 (275.1329)


   

N-BOC-1H-INDOLE-6-CARBOXYLIC ACID METHYL ESTER

N-BOC-1H-INDOLE-6-CARBOXYLIC ACID METHYL ESTER

C15H17NO4 (275.1158)


   

Trisguanidinium phosphate

Trisguanidinium phosphate

C3H18N9O4P (275.1219)


   

1-TERT-BUTYL 4-METHYL 1H-INDOLE-1,4-DICARBOXYLATE

1-TERT-BUTYL 4-METHYL 1H-INDOLE-1,4-DICARBOXYLATE

C15H17NO4 (275.1158)


   

Boc-L-citrulline

Boc-L-citrulline

C11H21N3O5 (275.1481)


   

1-(DIPHENYLMETHYL)-3-HYDROXYAZETIDINE HYDROCHLORIDE

1-(DIPHENYLMETHYL)-3-HYDROXYAZETIDINE HYDROCHLORIDE

C16H18ClNO (275.1077)


   

4-(2-(3-Trifluoromethylphenoxy)ethyl)morpholine

4-(2-(3-Trifluoromethylphenoxy)ethyl)morpholine

C13H16F3NO2 (275.1133)


   

(2S,4R)-N-Boc-4-acetylthio-2-hydroxymethyl-1-pyrrolidinecarboxylic acid

(2S,4R)-N-Boc-4-acetylthio-2-hydroxymethyl-1-pyrrolidinecarboxylic acid

C12H21NO4S (275.1191)


   

3-(4-BENZYL-PHENOXY)-PHENYLAMINE

3-(4-BENZYL-PHENOXY)-PHENYLAMINE

C19H17NO (275.131)


   

2H-Thiopyran-4-acetic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]tetrahydro

2H-Thiopyran-4-acetic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]tetrahydro

C12H21NO4S (275.1191)


   

4-Methoxytriphenylamine

4-Methoxytriphenylamine

C19H17NO (275.131)


   

O-Tritylhydroxylamine

O-Tritylhydroxylamine

C19H17NO (275.131)


   

1-tert-Butyl 7-methyl 1H-indole-1,7-dicarboxylate

1-tert-Butyl 7-methyl 1H-indole-1,7-dicarboxylate

C15H17NO4 (275.1158)


   
   

Ethyl 2-amino-5-(4-nitrophenyl)-1H-pyrrole-3-carboxylate

Ethyl 2-amino-5-(4-nitrophenyl)-1H-pyrrole-3-carboxylate

C13H13N3O4 (275.0906)


   

1-Pyrrolidinecarboxylic acid, 4-(acetylthio)-2-(hydroxymethyl)-, 1,1-dimethylethyl ester, (2S,4S)

1-Pyrrolidinecarboxylic acid, 4-(acetylthio)-2-(hydroxymethyl)-, 1,1-dimethylethyl ester, (2S,4S)

C12H21NO4S (275.1191)


   

(1-(TERT-BUTOXYCARBONYL)-4-METHYL-1H-INDOL-2-YL)BORONIC ACID

(1-(TERT-BUTOXYCARBONYL)-4-METHYL-1H-INDOL-2-YL)BORONIC ACID

C14H18BNO4 (275.1329)


   

1-Boc-3-Formyl-6-methoxyindole

1-Boc-3-Formyl-6-methoxyindole

C15H17NO4 (275.1158)


   

Spiro[piperidine-4,2(3aH)-thiazolo[5,4-c]pyridine],4,5,6,7-tetrahydro-1,5-dimethyl-, hydrochloride (1:2)

Spiro[piperidine-4,2(3aH)-thiazolo[5,4-c]pyridine],4,5,6,7-tetrahydro-1,5-dimethyl-, hydrochloride (1:2)

C12H22ClN3S (275.1223)


   

1-BOC-5-METHOXY-3-FORMYLINDOLE

1-BOC-5-METHOXY-3-FORMYLINDOLE

C15H17NO4 (275.1158)


   

3-Morpholin-4-yl-5-trifluoromethyl-benzoic acid

3-Morpholin-4-yl-5-trifluoromethyl-benzoic acid

C12H12F3NO3 (275.0769)


   
   

2-(tert-Butylamino)-4′-chloropropiophenone hydrochloride

2-(tert-Butylamino)-4′-chloropropiophenone hydrochloride

C13H19Cl2NO (275.0844)


   

1-(benzhydrylamino)-3-chloropropan-2-ol

1-(benzhydrylamino)-3-chloropropan-2-ol

C16H18ClNO (275.1077)


   

3-PHENYL-4-(1H-TETRAZOL-5-YLCARBAMOYL)-BUTYRIC ACID

3-PHENYL-4-(1H-TETRAZOL-5-YLCARBAMOYL)-BUTYRIC ACID

C12H13N5O3 (275.1018)


   

ART-CHEM-BB B018082

ART-CHEM-BB B018082

C14H17N3OS (275.1092)


   

3-[(3,5-dimethylphenoxy)methyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione

3-[(3,5-dimethylphenoxy)methyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione

C14H17N3OS (275.1092)


   

CHEMBRDG-BB 3000814

CHEMBRDG-BB 3000814

C15H17NO2S (275.098)


   

3-methoxy-N,N-diphenylaniline

3-methoxy-N,N-diphenylaniline

C19H17NO (275.131)


   

Choline tosylate

Choline tosylate

C12H21NO4S (275.1191)


Choline tosylate is a nucleophilic compound that inhibits phospholipase A2 and phospholipase C. Choline tosylate inhibits tumor growth in mice by inhibiting the formation of diacylglycerol (DAG)[1][2].

   

Bethanidine Sulfate

Bethanidine Sulfate

C10H17N3O4S (275.094)


   

5-oxo-DL-proline, compound with DL-lysine (1:1)

5-oxo-DL-proline, compound with DL-lysine (1:1)

C11H21N3O5 (275.1481)


   

Ethyl N-Boc-2-thiomorpholinecarboxylate

Ethyl N-Boc-2-thiomorpholinecarboxylate

C12H21NO4S (275.1191)


   

ART-CHEM-BB B018138

ART-CHEM-BB B018138

C14H17N3OS (275.1092)


   

ART-CHEM-BB B018144

ART-CHEM-BB B018144

C14H17N3OS (275.1092)


   

ART-CHEM-BB B018063

ART-CHEM-BB B018063

C14H17N3OS (275.1092)


   

ART-CHEM-BB B018141

ART-CHEM-BB B018141

C14H17N3OS (275.1092)


   

1-Pentanone-5-methoxy-1-[4-(trifluoromethyl)phenyl]-oxime

1-Pentanone-5-methoxy-1-[4-(trifluoromethyl)phenyl]-oxime

C13H16F3NO2 (275.1133)


   

2-(1,2,3,4-TETRAHYDROISOQUINOLIN-1-YL)-1-NAPHTHOL

2-(1,2,3,4-TETRAHYDROISOQUINOLIN-1-YL)-1-NAPHTHOL

C19H17NO (275.131)


   

8-cyclopentyl-5-Methyl-2-(Methylthio)pyrido[2,3-d]pyrimidin-7(8H)-one

8-cyclopentyl-5-Methyl-2-(Methylthio)pyrido[2,3-d]pyrimidin-7(8H)-one

C14H17N3OS (275.1092)


   

Levalbuterol Hydrochloride

Levalbuterol Hydrochloride

C13H22ClNO3 (275.1288)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist Levalbuterol ((R)-Albuterol) hydrochloride is a short-acting β2-adrenergic receptor agonist and the active (R)-enantiomer of Salbutamol. Levalbuterol hydrochloride is a more potent bronchodilator than Salbutamol and has the potential for the treatment of COPD[1].

   

ethyl (E)-3-(4-fluorophenyl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate

ethyl (E)-3-(4-fluorophenyl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate

C14H14FN3O2 (275.107)


   

METHYL 4-(MORPHOLINOCARBONYL)CUBANECARBOXYLATE

METHYL 4-(MORPHOLINOCARBONYL)CUBANECARBOXYLATE

C15H17NO4 (275.1158)


   

Ibafloxacin

Ibafloxacin

C15H14FNO3 (275.0958)


C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

   
   

4-CYANO-3-FLUOROPHENYL TRANS-4-ETHYLCYCLOHEXANECARBOXYLATE

4-CYANO-3-FLUOROPHENYL TRANS-4-ETHYLCYCLOHEXANECARBOXYLATE

C16H18FNO2 (275.1322)


   

4-ALLYL-5-(4-ETHYL-PHENOXYMETHYL)-4H-[1,2,4]TRIAZOLE-3-THIOL

4-ALLYL-5-(4-ETHYL-PHENOXYMETHYL)-4H-[1,2,4]TRIAZOLE-3-THIOL

C14H17N3OS (275.1092)


   

ART-CHEM-BB B018088

ART-CHEM-BB B018088

C14H17N3OS (275.1092)


   

ethyl 3-[ethoxycarbonyl-(2-ethoxy-2-oxoethyl)amino]propanoate

ethyl 3-[ethoxycarbonyl-(2-ethoxy-2-oxoethyl)amino]propanoate

C12H21NO6 (275.1369)


   

Ethyl 4-phthalimidoacetoacetate

Ethyl 4-phthalimidoacetoacetate

C14H13NO5 (275.0794)


   

ETHYL 2-METHYL-5-(4-NITROPHENYL)-3-FUROATE

ETHYL 2-METHYL-5-(4-NITROPHENYL)-3-FUROATE

C14H13NO5 (275.0794)


   

ETHYL 6-METHOXY-7-METHYL-6H-[1,2,5]OXADIAZOLO[3,4-E]INDOLE-8-CARBOXYLATE

ETHYL 6-METHOXY-7-METHYL-6H-[1,2,5]OXADIAZOLO[3,4-E]INDOLE-8-CARBOXYLATE

C13H13N3O4 (275.0906)


   

(1-(TERT-BUTYLDIMETHYLSILYL)-1H-INDOL-3-YL)BORONIC ACID

(1-(TERT-BUTYLDIMETHYLSILYL)-1H-INDOL-3-YL)BORONIC ACID

C14H22BNO2Si (275.1513)


   

1-Boc-5-Methyl-1H-indole-2-boronic acid

1-Boc-5-Methyl-1H-indole-2-boronic acid

C14H18BNO4 (275.1329)


   

1-BOC-6-methylindole-2-boronic acid

1-BOC-6-methylindole-2-boronic acid

C14H18BNO4 (275.1329)


   

1-(tert-Butyldimethylsilyl)-1H-indole-4-boronic acid

1-(tert-Butyldimethylsilyl)-1H-indole-4-boronic acid

C14H22BNO2Si (275.1513)


   

(1-(TERT-BUTYLDIMETHYLSILYL)-1H-INDOL-6-YL)BORONIC ACID

(1-(TERT-BUTYLDIMETHYLSILYL)-1H-INDOL-6-YL)BORONIC ACID

C14H22BNO2Si (275.1513)


   

4-(5-cyanopyridin-2-yl)-n-methyl-1,4-diazepane-1-carbothioamide

4-(5-cyanopyridin-2-yl)-n-methyl-1,4-diazepane-1-carbothioamide

C13H17N5S (275.1205)


   

(S)-3-(PIPERAZIN-1-YL)PROPANE-1,2-DIOL

(S)-3-(PIPERAZIN-1-YL)PROPANE-1,2-DIOL

C12H18ClNO4 (275.0924)


   

Ethyl 4-fluoro-D-leucinate sulfate

Ethyl 4-fluoro-D-leucinate sulfate

C8H18FNO6S (275.0839)


   

(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide

(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide

C14H17N3O3 (275.127)


   

METHYL 3-(2-CARBOXY-VINYL)-5-METHOXY-1H-INDOLE-2-CARBOXYLATE

METHYL 3-(2-CARBOXY-VINYL)-5-METHOXY-1H-INDOLE-2-CARBOXYLATE

C14H13NO5 (275.0794)


   

N-Tosyl-α-methylbenzenemethaneamine

N-Tosyl-α-methylbenzenemethaneamine

C15H17NO2S (275.098)


   

N-methyl ,ethyl-Morpholinium hexafluorophosphate

N-methyl ,ethyl-Morpholinium hexafluorophosphate

C7H16F6NOP (275.0874)


   

Methyl (S)-4-Methylene-1-(benzyloxycarbonyl)pyrrolidine carboxylate

Methyl (S)-4-Methylene-1-(benzyloxycarbonyl)pyrrolidine carboxylate

C15H17NO4 (275.1158)


   

2-Fluoro-N-(2,5-diMethoxyphenyl)benzaMide, 97\\%

2-Fluoro-N-(2,5-diMethoxyphenyl)benzaMide, 97\\%

C15H14FNO3 (275.0958)


   

Cipamfylline

Cipamfylline

C13H17N5O2 (275.1382)


C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   

2-Azaspiro[3.3]heptane-2,6-dicarboxylic acid 2-benzyl ester

2-Azaspiro[3.3]heptane-2,6-dicarboxylic acid 2-benzyl ester

C15H17NO4 (275.1158)


   

Ethyl 5-(acetyloxy)-1,2-dimethyl-1H-indole-3-carboxylate

Ethyl 5-(acetyloxy)-1,2-dimethyl-1H-indole-3-carboxylate

C15H17NO4 (275.1158)


   

7-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE

7-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE

C14H18BNO4 (275.1329)


   

ethyl 3-amino-1-[(4-methoxyphenyl)methyl]pyrazole-4-carboxylate

ethyl 3-amino-1-[(4-methoxyphenyl)methyl]pyrazole-4-carboxylate

C14H17N3O3 (275.127)


   

triphenylsilanamine

triphenylsilanamine

C18H17NSi (275.113)


   

Methyldopate hydrochloride

Methyldopate hydrochloride

C12H18ClNO4 (275.0924)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

Meturedepa

Carbamic acid,N-[bis(2,2-dimethyl-1-aziridinyl)phosphinyl]-, ethyl ester

C11H22N3O3P (275.1399)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

(1-(tert-Butyldimethylsilyl)-1H-indol-5-yl)boronic acid

(1-(tert-Butyldimethylsilyl)-1H-indol-5-yl)boronic acid

C14H22BNO2Si (275.1513)


   

5-(4-DIETHYLAMINO-BENZYLIDENE)-2-THIOXO-IMIDAZOLIDIN-4-ONE

5-(4-DIETHYLAMINO-BENZYLIDENE)-2-THIOXO-IMIDAZOLIDIN-4-ONE

C14H17N3OS (275.1092)


   

6-[4-(DIMETHYLAMINO)PHENYL]-1,2,5,6-TETRAHYDRO-4-METHYL-2-OXO-5-PYRIMIDINECARBOX

6-[4-(DIMETHYLAMINO)PHENYL]-1,2,5,6-TETRAHYDRO-4-METHYL-2-OXO-5-PYRIMIDINECARBOX

C14H17N3O3 (275.127)


   

2-Pyridinemethanol, 4-[4-(methylamino)-3-nitrophenoxy]

2-Pyridinemethanol, 4-[4-(methylamino)-3-nitrophenoxy]

C13H13N3O4 (275.0906)


   

5,6-DIHYDRO-5-OXO-1,3(4H)-PYRIDINEDICARBOXYLIC ACID, 3-METHYL 1-PHENYL ESTER

5,6-DIHYDRO-5-OXO-1,3(4H)-PYRIDINEDICARBOXYLIC ACID, 3-METHYL 1-PHENYL ESTER

C14H13NO5 (275.0794)


   

N-[6-(chloromethyl)naphthalen-2-yl]-2,2-dimethylpropanamide

N-[6-(chloromethyl)naphthalen-2-yl]-2,2-dimethylpropanamide

C16H18ClNO (275.1077)


   

4,4,4-TRIMETHYL-2,2:6,2-TERPYRIDINE

4,4,4-TRIMETHYL-2,2:6,2-TERPYRIDINE

C18H17N3 (275.1422)


   

4-Nitro-p-terphenyl

4-Nitro-p-terphenyl

C18H13NO2 (275.0946)


   

ethyl 2-amino-5-(1-phenylethyl)thiophene-3-carboxylate

ethyl 2-amino-5-(1-phenylethyl)thiophene-3-carboxylate

C15H17NO2S (275.098)


   

1-tert-Butyl 3-methyl 1H-indole-1,3-dicarboxylate

1-tert-Butyl 3-methyl 1H-indole-1,3-dicarboxylate

C15H17NO4 (275.1158)


   

Benzenesulfonamide,N-(2,6-dimethylphenyl)-4-methyl-

Benzenesulfonamide,N-(2,6-dimethylphenyl)-4-methyl-

C15H17NO2S (275.098)


   

METHYL (2S)-1-CBZ-1,2,3,4-TETRAHYDRO-2-PYRIDINECARBOXYLATE

METHYL (2S)-1-CBZ-1,2,3,4-TETRAHYDRO-2-PYRIDINECARBOXYLATE

C15H17NO4 (275.1158)


   

1-(4-NITRO-3-TRIFLUOROMETHYLPHENYL)-PIPERAZINE

1-(4-NITRO-3-TRIFLUOROMETHYLPHENYL)-PIPERAZINE

C11H12F3N3O2 (275.0882)


   

4-Chloro-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine

4-Chloro-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine

C14H14ClN3O (275.0825)


   

DIETHYL2-(TERT-BUTOXYCARBONYLAMINO)MALONATE

DIETHYL2-(TERT-BUTOXYCARBONYLAMINO)MALONATE

C12H21NO6 (275.1369)


   

Omigapil

Omigapil

C19H17NO (275.131)


C471 - Enzyme Inhibitor

   

4-Methoxy-N-((4-(trifluoromethyl)phenyl)methyl)-butanamide

4-Methoxy-N-((4-(trifluoromethyl)phenyl)methyl)-butanamide

C13H16F3NO2 (275.1133)


   

[4-Amino-2-(Tert-Butylamino)-1,3-Thiazol-5-Yl](Phenyl)methanone

[4-Amino-2-(Tert-Butylamino)-1,3-Thiazol-5-Yl](Phenyl)methanone

C14H17N3OS (275.1092)


   

Isoetharine hydrochloride

Isoetharine hydrochloride

C13H22ClNO3 (275.1288)


   

Benzo[a]phenoxazin-9-ylidene(dimethyl)azanium

Benzo[a]phenoxazin-9-ylidene(dimethyl)azanium

C18H15N2O+ (275.1184)


   

quinolin-8-yl (E)-3-phenylprop-2-enoate

quinolin-8-yl (E)-3-phenylprop-2-enoate

C18H13NO2 (275.0946)


   

N-(2-phenylphenyl)-2-pyrazinecarboxamide

N-(2-phenylphenyl)-2-pyrazinecarboxamide

C17H13N3O (275.1059)


   

5,6-dimethyl-2-[2-(1-pyrrolidinyl)ethylthio]-1H-benzimidazole

5,6-dimethyl-2-[2-(1-pyrrolidinyl)ethylthio]-1H-benzimidazole

C15H21N3S (275.1456)


   

3-methoxy-N-[(E)-2-(3-methyl-4-nitro-1,2-oxazol-5-yl)ethenyl]aniline

3-methoxy-N-[(E)-2-(3-methyl-4-nitro-1,2-oxazol-5-yl)ethenyl]aniline

C13H13N3O4 (275.0906)


   
   

5-Methyl-2-((4R)-4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) nicotinic acid

5-Methyl-2-((4R)-4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) nicotinic acid

C14H17N3O3 (275.127)


   

5-Methyl-2-((4S)-4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) nicotinic acid

5-Methyl-2-((4S)-4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) nicotinic acid

C14H17N3O3 (275.127)


   

L-Serine, glycyl-L-leucyl-

L-Serine, glycyl-L-leucyl-

C11H21N3O5 (275.1481)


   

L-lysyl-D-glutamic acid

L-lysyl-D-glutamic acid

C11H21N3O5 (275.1481)


   

Obscurolide A2

Obscurolide A2

C15H17NO4 (275.1158)


   

3-(Naphthalen-1-ylmethyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine

3-(Naphthalen-1-ylmethyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine

C16H13N5 (275.1171)


   

(1R)-1-(2-Thienylacetylamino)-1-phenylmethylboronic acid

(1R)-1-(2-Thienylacetylamino)-1-phenylmethylboronic acid

C13H14BNO3S (275.0787)


   

1-Methyl-3-Naphthalen-2-Yl-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine

1-Methyl-3-Naphthalen-2-Yl-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine

C16H13N5 (275.1171)


   

(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one

(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one

C13H14FN5O (275.1182)


   

2-[(4Z)-2-(aminomethyl)-4-[(4-hydroxyphenyl)methylidene]-5-oxoimidazol-1-yl]acetic acid

2-[(4Z)-2-(aminomethyl)-4-[(4-hydroxyphenyl)methylidene]-5-oxoimidazol-1-yl]acetic acid

C13H13N3O4 (275.0906)


   

3773-08-8

(2S)-2-amino-5-[[(1S)-2-(carboxymethylamino)-2-keto-1-methyl-ethyl]amino]-5-keto-valeric acid

C10H17N3O6 (275.1117)


   

4-[[2-(3-Hydroxybut-1-enyl)-5-oxooxolan-3-yl]amino]benzaldehyde

4-[[2-(3-Hydroxybut-1-enyl)-5-oxooxolan-3-yl]amino]benzaldehyde

C15H17NO4 (275.1158)


   

N-gamma-Glutamylglutamine

N-gamma-Glutamylglutamine

C10H17N3O6 (275.1117)


   

4-Amino-5-[(4-amino-1-carboxy-4-oxobutyl)amino]-5-oxopentanoic acid

4-Amino-5-[(4-amino-1-carboxy-4-oxobutyl)amino]-5-oxopentanoic acid

C10H17N3O6 (275.1117)


   

3-(4-Hydroxy-3,5-dimethoxyphenyl)propanoylpyrrole

3-(4-Hydroxy-3,5-dimethoxyphenyl)propanoylpyrrole

C15H17NO4 (275.1158)


A natural product found in Piper boehmeriaefolium.

   

lysylglutamic acid, Lys-Glu, H-LYS-GLU-OH, Peptide vilon

lysylglutamic acid, Lys-Glu, H-LYS-GLU-OH, Peptide vilon

C11H21N3O5 (275.1481)


   

epsilon-(gamma-Glutamyl)-L-lysine

2,6,10-triamino-5-oxoundecanedioic acid

C11H21N3O5 (275.1481)


   

L-saccharopinate(1-)

L-saccharopinate(1-)

C11H19N2O6- (275.1243)


The conjugate base of L-saccharopine arising from deprotonation of all three carboxy groups and protonation of the primary and secondary amino groups; major species at pH 7.3.

   

Arenaemycin E

Arenaemycin E

C15H15O5- (275.0919)


   

4-Formyl-3-hydroxy-7-methyl-5,8-dioxo-1-propan-2-yl-6,7-dihydronaphthalen-2-olate

4-Formyl-3-hydroxy-7-methyl-5,8-dioxo-1-propan-2-yl-6,7-dihydronaphthalen-2-olate

C15H15O5- (275.0919)


   

Neopentalenolactone

Neopentalenolactone

C15H15O5- (275.0919)


   

alpha-D-ManNAc3NAmA

alpha-D-ManNAc3NAmA

C10H17N3O6 (275.1117)


   

2,3-diacetamido-2,3-dideoxy-alpha-D-mannuronate

2,3-diacetamido-2,3-dideoxy-alpha-D-mannuronate

C10H15N2O7- (275.0879)


   

(2S,3S,4R,5S,6S)-5-acetamido-4-(1-aminoethylideneamino)-3,6-dihydroxyoxane-2-carboxylic acid

(2S,3S,4R,5S,6S)-5-acetamido-4-(1-aminoethylideneamino)-3,6-dihydroxyoxane-2-carboxylic acid

C10H17N3O6 (275.1117)


   

Lysylglutamic acid

Lysylglutamic acid

C11H21N3O5 (275.1481)


D020011 - Protective Agents

   

2-[(4-Aminophenoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(4-Aminophenoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C11H20N2O4P+ (275.1161)


   

2-Ethylpropanedioylcarnitine

2-Ethylpropanedioylcarnitine

C12H21NO6 (275.1369)


   

[(1S,2S,4S,5S)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)-4-bicyclo[3.1.0]hexanyl]methanol

[(1S,2S,4S,5S)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)-4-bicyclo[3.1.0]hexanyl]methanol

C13H17N5O2 (275.1382)


   

(2S,3S,5R)-5-(6-Aminopurin-9-yl)-2-(2H-oxet-2-yl)oxolan-3-ol

(2S,3S,5R)-5-(6-Aminopurin-9-yl)-2-(2H-oxet-2-yl)oxolan-3-ol

C12H13N5O3 (275.1018)


   

Ala-Ala-Asp

Ala-Ala-Asp

C10H17N3O6 (275.1117)


A tripeptide composed of two L-alanyl and an L-aspartic acid residue joined in sequence.

   

N,4-dimethyl-N-(4-methylphenyl)benzenesulfonamide

N,4-dimethyl-N-(4-methylphenyl)benzenesulfonamide

C15H17NO2S (275.098)


   
   

2-(2-furanyl)-N-phenyl-3-imidazo[1,2-a]pyridinamine

2-(2-furanyl)-N-phenyl-3-imidazo[1,2-a]pyridinamine

C17H13N3O (275.1059)


   

N-(4-methylphenyl)-4-benzofuro[3,2-d]pyrimidinamine

N-(4-methylphenyl)-4-benzofuro[3,2-d]pyrimidinamine

C17H13N3O (275.1059)


   

4-amino-N-[(E)-(4-nitrophenyl)methylidene]-1,2,5-oxadiazole-3-carbohydrazonamide

4-amino-N-[(E)-(4-nitrophenyl)methylidene]-1,2,5-oxadiazole-3-carbohydrazonamide

C10H9N7O3 (275.0767)


   

1-[2-(4-Methoxyphenyl)ethyl]-3,5-dimethyl-4-nitropyrazole

1-[2-(4-Methoxyphenyl)ethyl]-3,5-dimethyl-4-nitropyrazole

C14H17N3O3 (275.127)


   
   
   
   
   

2-Methoxy-4-[[2-(methylthio)anilino]methyl]phenol

2-Methoxy-4-[[2-(methylthio)anilino]methyl]phenol

C15H17NO2S (275.098)


   

2-[(3-Fluoro-4-methoxyphenyl)methoxy]benzamide

2-[(3-Fluoro-4-methoxyphenyl)methoxy]benzamide

C15H14FNO3 (275.0958)


   

1-(1-Naphthalenylmethoxy)benzotriazole

1-(1-Naphthalenylmethoxy)benzotriazole

C17H13N3O (275.1059)


   

N-(3,4-dihydro-1H-[1,4]thiazino[4,3-a]benzimidazol-8-yl)butanamide

N-(3,4-dihydro-1H-[1,4]thiazino[4,3-a]benzimidazol-8-yl)butanamide

C14H17N3OS (275.1092)


   

(E)-N-[2-(1-methyltetrazol-5-yl)sulfanylethyl]-3-phenylprop-2-en-1-amine

(E)-N-[2-(1-methyltetrazol-5-yl)sulfanylethyl]-3-phenylprop-2-en-1-amine

C13H17N5S (275.1205)


   

Acetic acid 2-[[oxo-(2-oxo-1-benzopyran-3-yl)methyl]amino]ethyl ester

Acetic acid 2-[[oxo-(2-oxo-1-benzopyran-3-yl)methyl]amino]ethyl ester

C14H13NO5 (275.0794)


   

2-(2-Chlorophenyl)-5-(2-methylpropylamino)-4-oxazolecarbonitrile

2-(2-Chlorophenyl)-5-(2-methylpropylamino)-4-oxazolecarbonitrile

C14H14ClN3O (275.0825)


   

N-(2-furanylmethyl)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxamide

N-(2-furanylmethyl)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxamide

C15H17NO2S (275.098)


   

2-(Hydroxymethyl)-3-(5-nitro-2-pyrrolidin-1-ylphenyl)propanenitrile

2-(Hydroxymethyl)-3-(5-nitro-2-pyrrolidin-1-ylphenyl)propanenitrile

C14H17N3O3 (275.127)


   

(3R)-3-{[(3R)-3-{[(3R)-3-hydroxybutanoyl]oxy}butanoyl]oxy}butanoate

(3R)-3-{[(3R)-3-{[(3R)-3-hydroxybutanoyl]oxy}butanoyl]oxy}butanoate

C12H19O7- (275.1131)


A hydroxy monocarboxylic acid anion resulting from the deprotonation of the carboxy group of (3R)-3-{[(3R)-3-{[(3R)-3-hydroxybutanoyl]oxy}butanoyl]oxy}butanoic acid. It is a trimer of (3R)-hydroxybutanoate; major microspecies at pH 7.3.

   

2-[(3-Phenyl-1-indazolyl)methyl]oxazole

2-[(3-Phenyl-1-indazolyl)methyl]oxazole

C17H13N3O (275.1059)


   

N-butyl-5-(3,4-dimethylphenyl)-6H-1,3,4-thiadiazin-2-amine

N-butyl-5-(3,4-dimethylphenyl)-6H-1,3,4-thiadiazin-2-amine

C15H21N3S (275.1456)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

5-(6-Aminohexanamido)isatin

5-(6-Aminohexanamido)isatin

C14H17N3O3 (275.127)


   

Acetic acid [3-[3-(dimethylamino)-1-oxopropyl]-5-benzofuranyl] ester

Acetic acid [3-[3-(dimethylamino)-1-oxopropyl]-5-benzofuranyl] ester

C15H17NO4 (275.1158)


   

(4E,6E)-3-(4-formylanilino)-8-hydroxyocta-4,6-dienoic acid

(4E,6E)-3-(4-formylanilino)-8-hydroxyocta-4,6-dienoic acid

C15H17NO4 (275.1158)


   

3-[4-[(1S,5R)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

3-[4-[(1S,5R)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C18H17N3 (275.1422)


   

1-Naphthalen-2-ylimino-3-phenylurea

1-Naphthalen-2-ylimino-3-phenylurea

C17H13N3O (275.1059)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(6R)-6-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]heptanoate

(6R)-6-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]heptanoate

C13H23O6- (275.1495)


   

7-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]heptanoate

7-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]heptanoate

C13H23O6- (275.1495)


   

6-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxohexanoate

6-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxohexanoate

C12H19O7- (275.1131)


   

(5R)-5-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxohexanoate

(5R)-5-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxohexanoate

C12H19O7- (275.1131)


   

(3R)-3-(4-carboxybutanoyloxy)-4-[methyl-bis(trideuteriomethyl)azaniumyl]butanoate

(3R)-3-(4-carboxybutanoyloxy)-4-[methyl-bis(trideuteriomethyl)azaniumyl]butanoate

C12H21NO6 (275.1369)


   

epsilon-(gamma-Glutamyl)lysine

epsilon-(gamma-Glutamyl)-lysine

C11H21N3O5 (275.1481)


An N(6)-acyl-L-lysine derivative in which the acyl group is specified as gamma-glutamyl.

   

2-(2-Acetylamino-4-hydroxy-6,8-dioxa-bicyclo[3.2.1]oct-3-yloxy)-propionic acid

2-(2-Acetylamino-4-hydroxy-6,8-dioxa-bicyclo[3.2.1]oct-3-yloxy)-propionic acid

C11H17NO7 (275.1005)


   
   

Norophthalamic acid

Norophthalamic acid

C10H17N3O6 (275.1117)


   

epsilon-(gamma-L-Glutamyl)-L-lysine

epsilon-(gamma-L-Glutamyl)-L-lysine

C11H21N3O5 (275.1481)


   

pentalenolactone(1-)

pentalenolactone(1-)

C15H15O5 (275.0919)


A monocarboxylic acid anion that is the conjugate base of pentalenolactone, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

H-Ala-Trp-OH

L-Alanyl-L-tryptophan

C14H17N3O3 (275.127)


   

Lys-glu

Lys-glu

C11H21N3O5 (275.1481)


A dipeptide formed from L-lysine and L-glutamic acid residues.

   

Glu-Lys

H-Glu-Lys-OH

C11H21N3O5 (275.1481)


A dipeptide composed of L-glutamic acid and L-lysine joined by a peptide linkage.

   

Gamma-glutamyl-Lysine

Gamma-glutamyl-Lysine

C11H21N3O5 (275.1481)


   

GLN-Glu

GLN-Glu

C10H17N3O6 (275.1117)


A dipeptide formed from L-glutamine and L-glutamic acid residues.

   

O-glutarylcarnitine

O-glutarylcarnitine

C12H21NO6 (275.1369)


An O-acylcarnitine having glutaryl as the acyl substituent.

   

Glutamylglutamine

Glutamylglutamine

C10H17N3O6 (275.1117)


   

Glutamyl-Gamma-glutamate

Glutamyl-Gamma-glutamate

C10H17N3O6 (275.1117)


   

(3S)-3-[(4-carboxybutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

(3S)-3-[(4-carboxybutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H21NO6 (275.1369)


   

1,N6-Ethenodeoxyadenosine

1,N6-Ethenodeoxyadenosine

C12H13N5O3 (275.1018)


N6-Etheno 2'-deoxyadenosine is a reactive oxygen species (ROS)/reactive nitrogen species (RNS)-induced DNA oxidation product, used as a biomarker to evaluate chronic inflammation and lipid peroxidation in animal or human tissues[1].

   

gamma-Glu-Gln

gamma-Glu-Gln

C10H17N3O6 (275.1117)


A dipeptide obtained by formal condensation of the gamma-carboxy group of glutamic acid with the amino group of glutamine

   

oscr#1(1-)

oscr#1(1-)

C13H23O6 (275.1495)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#1, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

O-Glutaroyl-L-carnitine

O-Glutaroyl-L-carnitine

C12H21NO6 (275.1369)


An O-acyl-L-carnitine in which the acyl group is specified as glutaroyl.

   

epsilon-(gamma-glutamyl)lysine dizwitterion

epsilon-(gamma-glutamyl)lysine dizwitterion

C11H21N3O5 (275.1481)


An L-alpha-amino acid zwitterion that is the dizwitterionic form of epsilon-(gamma-glutamyl)lysine obtained by migration of protons from both carboxy groups to the amino groups; major species at pH 7.3.

   

ascr#1(1-)

ascr#1(1-)

C13H23O6 (275.1495)


A monocarboxylic acid anion resulting from the deprotonation of the carboxy group of ascr#1. The conjugate base of ascr#1 and the major species at pH 7.3.

   
   

N(2)-Succinyl-citrulline

N(2)-Succinyl-citrulline

C10H17N3O6 (275.1117)


   

Cyclo(Gln-Phe)

Cyclo(Gln-Phe)

C14H17N3O3 (275.127)


   
   

MFI8

MFI8

C16H18ClNO (275.1077)


MFI8 is a small molecule inhibitor of mitochondrial[1].

   

(3r,4s)-3,4-dihydroxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

(3r,4s)-3,4-dihydroxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

C15H17NO4 (275.1158)


   

4-{[5-oxo-2-(3-oxobutyl)oxolan-3-yl]amino}benzaldehyde

4-{[5-oxo-2-(3-oxobutyl)oxolan-3-yl]amino}benzaldehyde

C15H17NO4 (275.1158)


   

(2r)-2-[(2r)-4-methoxy-2h,3h-furo[2,3-b]quinolin-2-yl]propane-1,2-diol

(2r)-2-[(2r)-4-methoxy-2h,3h-furo[2,3-b]quinolin-2-yl]propane-1,2-diol

C15H17NO4 (275.1158)


   

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-(1h-indol-3-yl)propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C14H17N3O3 (275.127)


   

(2e)-2-(hydroxymethyl)-4-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-enenitrile

(2e)-2-(hydroxymethyl)-4-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-enenitrile

C11H17NO7 (275.1005)


   

(2s)-6-amino-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}hexanoic acid

(2s)-6-amino-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}hexanoic acid

C11H21N3O5 (275.1481)


   

3,7-dihydroxy-2,2,10-trimethyl-3h,4h-pyrano[2,3-b]quinolin-5-one

3,7-dihydroxy-2,2,10-trimethyl-3h,4h-pyrano[2,3-b]quinolin-5-one

C15H17NO4 (275.1158)


   

6-amino-2-[(4-amino-4-carboxy-1-hydroxybutylidene)amino]hexanoic acid

6-amino-2-[(4-amino-4-carboxy-1-hydroxybutylidene)amino]hexanoic acid

C11H21N3O5 (275.1481)


   

(2s,3s)-2-(2-hydroxypropan-2-yl)-4-methoxy-2h,3h-furo[2,3-b]quinolin-3-ol

(2s,3s)-2-(2-hydroxypropan-2-yl)-4-methoxy-2h,3h-furo[2,3-b]quinolin-3-ol

C15H17NO4 (275.1158)


   

5-amino-6-(4-hydroxybut-2-enoyl)-2,2-dimethyl-3h-1-benzopyran-4-one

5-amino-6-(4-hydroxybut-2-enoyl)-2,2-dimethyl-3h-1-benzopyran-4-one

C15H17NO4 (275.1158)


   

4-{[2-(1-hydroxybut-2-en-1-yl)-5-oxooxolan-3-yl]amino}benzaldehyde

4-{[2-(1-hydroxybut-2-en-1-yl)-5-oxooxolan-3-yl]amino}benzaldehyde

C15H17NO4 (275.1158)


   

(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H17N3O6 (275.1117)


   

3-[(2s,5s)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propanimidic acid

3-[(2s,5s)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propanimidic acid

C14H17N3O3 (275.127)


   

3-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one

3-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one

C15H17NO4 (275.1158)


   

(2e,4e,6e)-n-(3-methylbutyl)-7-(thiophen-2-yl)hepta-2,4,6-trienimidic acid

(2e,4e,6e)-n-(3-methylbutyl)-7-(thiophen-2-yl)hepta-2,4,6-trienimidic acid

C16H21NOS (275.1344)


   

(2s,3r,4s,5s,6r)-2-{[(2r)-5-hydroxy-4-methyl-2h-pyrrol-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(2r)-5-hydroxy-4-methyl-2h-pyrrol-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C11H17NO7 (275.1005)


   

13-hydroxy-4-imino-6,11,11-trimethyl-9-oxa-3,5-diazatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2,6-trien-8-one

13-hydroxy-4-imino-6,11,11-trimethyl-9-oxa-3,5-diazatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2,6-trien-8-one

C14H17N3O3 (275.127)


   

(2s)-2-[(2r)-4-methoxy-2h,3h-furo[2,3-b]quinolin-2-yl]propane-1,2-diol

(2s)-2-[(2r)-4-methoxy-2h,3h-furo[2,3-b]quinolin-2-yl]propane-1,2-diol

C15H17NO4 (275.1158)


   

(2e)-3-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one

(2e)-3-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one

C15H17NO4 (275.1158)


   

(2z)-2-(hydroxymethyl)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-enenitrile

(2z)-2-(hydroxymethyl)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-enenitrile

C11H17NO7 (275.1005)


   

6-hydroxy-4-[2-(2-hydroxy-3,5-dimethylphenyl)-2-oxoethyl]-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-[2-(2-hydroxy-3,5-dimethylphenyl)-2-oxoethyl]-4,5-dihydro-3h-pyridin-2-one

C15H17NO4 (275.1158)


   

(2z)-3-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one

(2z)-3-(6-methoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one

C15H17NO4 (275.1158)


   

4-(2-chloroethyl)-3-hydroxy-1-(1-hydroxy-2-methylpropyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

4-(2-chloroethyl)-3-hydroxy-1-(1-hydroxy-2-methylpropyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

C12H18ClNO4 (275.0924)


   

(2s,3s)-7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.0²,⁸.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-3-amine

(2s,3s)-7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.0²,⁸.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-3-amine

C14H17N3OS (275.1092)


   

2-(1,2-dihydroxypropan-2-yl)-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one

2-(1,2-dihydroxypropan-2-yl)-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one

C15H17NO4 (275.1158)


   

2-[(5-hydroxy-4-methyl-2h-pyrrol-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(5-hydroxy-4-methyl-2h-pyrrol-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C11H17NO7 (275.1005)


   

4-hydroxy-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-2-enenitrile

4-hydroxy-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-2-enenitrile

C11H17NO7 (275.1005)


   

(2z)-4-hydroxy-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-2-enenitrile

(2z)-4-hydroxy-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-2-enenitrile

C11H17NO7 (275.1005)


   

2-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-enenitrile

2-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-enenitrile

C11H17NO7 (275.1005)


   

2-(2-hydroxypropan-2-yl)-4-methoxy-2h,3h-furo[2,3-b]quinolin-3-ol

2-(2-hydroxypropan-2-yl)-4-methoxy-2h,3h-furo[2,3-b]quinolin-3-ol

C15H17NO4 (275.1158)


   

(2s)-2-[(2s)-1,2-dihydroxypropan-2-yl]-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one

(2s)-2-[(2s)-1,2-dihydroxypropan-2-yl]-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one

C15H17NO4 (275.1158)


   

3-methyl-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxirane-2-carbonitrile

3-methyl-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxirane-2-carbonitrile

C11H17NO7 (275.1005)


   

(2s)-2-amino-4-{[(1s)-1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1s)-1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H17N3O6 (275.1117)


   

2-amino-4-{[1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

2-amino-4-{[1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H17N3O6 (275.1117)


   

(13r)-13-hydroxy-4-imino-6,11,11-trimethyl-9-oxa-3,5-diazatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2,6-trien-8-one

(13r)-13-hydroxy-4-imino-6,11,11-trimethyl-9-oxa-3,5-diazatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2,6-trien-8-one

C14H17N3O3 (275.127)


   

4-({2-[(1e)-3-hydroxybut-1-en-1-yl]-5-oxooxolan-3-yl}amino)benzaldehyde

4-({2-[(1e)-3-hydroxybut-1-en-1-yl]-5-oxooxolan-3-yl}amino)benzaldehyde

C15H17NO4 (275.1158)


   

4-({2-[(2e)-1-hydroxybut-2-en-1-yl]-5-oxooxolan-3-yl}amino)benzaldehyde

4-({2-[(2e)-1-hydroxybut-2-en-1-yl]-5-oxooxolan-3-yl}amino)benzaldehyde

C15H17NO4 (275.1158)


   

(3s)-3-hydroxy-4-(5-hydroxy-1,4-dioxonaphthalen-2-yl)butanimidic acid

(3s)-3-hydroxy-4-(5-hydroxy-1,4-dioxonaphthalen-2-yl)butanimidic acid

C14H13NO5 (275.0794)


   

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxypropylidene]amino}butanedioic acid

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxypropylidene]amino}butanedioic acid

C10H17N3O6 (275.1117)


   

(2s)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid

(2s)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid

C10H17N3O6 (275.1117)


   

3-hydroxy-7-methoxy-6-methyl-5-[(3-methylbut-2-en-1-yl)oxy]isoindol-1-one

3-hydroxy-7-methoxy-6-methyl-5-[(3-methylbut-2-en-1-yl)oxy]isoindol-1-one

C15H17NO4 (275.1158)


   

7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.0²,⁸.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-3-amine

7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.0²,⁸.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-3-amine

C14H17N3OS (275.1092)


   

3,4-dihydroxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

3,4-dihydroxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

C15H17NO4 (275.1158)


   

(1r,4r,5s)-4-(2-chloroethyl)-3-hydroxy-1-[(1s)-1-hydroxy-2-methylpropyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

(1r,4r,5s)-4-(2-chloroethyl)-3-hydroxy-1-[(1s)-1-hydroxy-2-methylpropyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

C12H18ClNO4 (275.0924)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}propanoic acid

C14H17N3O3 (275.127)


   

(2s)-6-hydroxy-2-(2-hydroxypropan-2-yl)-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one

(2s)-6-hydroxy-2-(2-hydroxypropan-2-yl)-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one

C15H17NO4 (275.1158)


   

(2s,3r)-3-methyl-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxirane-2-carbonitrile

(2s,3r)-3-methyl-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxirane-2-carbonitrile

C11H17NO7 (275.1005)


   

(3r)-3,7-dihydroxy-2,2,10-trimethyl-3h,4h-pyrano[2,3-b]quinolin-5-one

(3r)-3,7-dihydroxy-2,2,10-trimethyl-3h,4h-pyrano[2,3-b]quinolin-5-one

C15H17NO4 (275.1158)